Recent trends in preparation of poly(lactide-co-glycolide) nanoparticles by mixing polymeric organic solution with antisolvent

Journal of Nanomaterials

Volumn 2015, Issue , 2015, Pages

  Sah, Edel ^a   Sah, Hongkee ^b  

^a UNIVERSITY OF NOTRE DAME   (United States)

^b Ewha Womans University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

EMULSIFICATION; ENVIRONMENTAL IMPACT; HYBRID SYSTEMS; PERSONNEL SELECTION; WASTE DISPOSAL;

EMULSION SOLVENT EVAPORATION; MANUFACTURING COST; MEMBRANE EMULSIFICATION; MICROFLUIDIC TECHNOLOGIES; NANO PRECIPITATIONS; PLGA NANOPARTICLES; POLY LACTIDE-CO-GLYCOLIDE; TECHNOLOGICAL ASPECTS;

NANOPARTICLES;

EID: 84937239259     PISSN: 16874110     EISSN: 16874129     Source Type: Journal    
DOI: 10.1155/2015/794601     Document Type: Review

References (211)

1. R. Bawa, "Nanoparticle-based therapeutics in humans: a survey, " Nanotechnology Law and Business, vol. 5, no. 2, pp. 135-155, 2008.
2. J. M. Chan, P. M. Valencia, L. Zhang, R. Langer, and O. C. Farokhzad, "Polymeric nanoparticles for drug delivery, " in Cancer Nanotechnology, vol. 624 of Methods in Molecular Biology, pp. 163-175, Humana Press, 2010.
3. H. K. Makadia and S. J. Siegel, "Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier, " Polymers, vol. 3, no. 3, pp. 1377-1397, 2011.
4. H. Sah, L. A. Toma, H. R. Desu, E. Sah, and G. C. Wood, "Concepts and practices used to develop functional PLGA-based nanoparticulate systems, " International Journal of Nano-medicine, vol. 8, pp. 747-765, 2013.
5. V. Sanna, N. Pala, and M. Sechi, "Targeted therapy using nanotechnology: focus on cancer, " International Journal of Nanomedicine, vol. 9, no. 1, pp. 467-483, 2014.
6. C. Pinto Reis, R. J. Neufeld, A. J. Ribeiro, and F. Veiga, "Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles, " Nanomedicine: Nanotechnology, Biology, and Medicine, vol. 2, no. 1, pp. 8-21, 2006.
7. F. Danhier, E. Ansorena, J. M. Silva, R. Coco, A. Le Breton, and V. Préat, "PLGA-based nanoparticles: an overview of biomedical applications, " Journal of Controlled Release, vol. 161, no. 2, pp. 505-522, 2012.
8. B. Jeong, Y. H. Bae, and S. W. Kim, "In situ gelation of PEG-PLGA-PEG triblock copolymer aqueous solutions and degradation thereof, " Journal of Biomedical Materials Research, vol. 50, no. 2, pp. 171-177, 2000.
9. J. Cheng, B. A. Teply, I. Sherif et al., "Formulation of func-tionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery, " Biomaterials, vol. 28, no. 5, pp. 869-876, 2007.
10. Y. Nie, Z. R. Zhang, B. He, and Z. Gu, "Investigation of PEG-PLGA-PEG nanoparticles-based multipolyplexes for IL-18 gene delivery, " Journal of Biomaterials Applications, vol. 26, no. 8, pp. 893-916, 2012.
11. I. Bala, S. Hariharan, and M. N. V. R. Kumar, "PLGA nanopar-ticles in drug delivery: the state of the art, " Critical Reviews in Terapeutic Drug Carrier Systems, vol. 21, no. 5, pp. 387-422, 2004.
12. N. Anton, J.-P. Benoit, and P. Saulnier, "Design and production of nanoparticles formulated from nano-emulsion templates-a review, " Journal of Controlled Release, vol. 128, no. 3, pp. 185-199, 2008.
13. R. Kumar, G. Troiano, J. M. Ramstack, P. Herbert, and M. Figa, "Coacervation process, " European Patent EP 2131815, 2012.
14. M. Nahar and N. K. Jain, "Preparation, characterization and evaluation of targeting potential of amphotericin B-loaded engineered PLGA nanoparticles, " Pharmaceutical Research, vol. 26, no. 12, pp. 2588-2598, 2009.
15. I. Özcan, E. Azizoglu, T. Şenyigit, M. Özyazici, and Ö. Özer, "Comparison of PLGA and lecithin/chitosan nanoparticles for dermal targeting of betamethasone valerate, " Journal of Drug Targeting, vol. 21, no. 6, pp. 542-550, 2013.
16. P. Yin, Y. Wang, Y. Y. Qiu et al., "Bufalin-loaded mPEG-PLGA-PLL-cRGD nanoparticles: preparation, cellular uptake, tissue distribution, and anticancer activity, " International Journal of Nanomedicine, vol. 7, pp. 3961-3969, 2012.
17. C. Matthäus, S. Schubert, M. Schmitt et al., "Resonance Raman spectral imaging of intracellular uptake of carotene loaded poly(D, L-lactide-glycolide) nanoparticles, " ChemPhysChem, vol. 14, no. 1, pp. 155-161, 2013.
18. M. M. Ibrahim, A.-E. H. Abd-Elgawad, O. A.-E. Soliman, and M. M. Jablonski, "Nanoparticle-based topical ophthalmic formulations for sustained celecoxib release, " Journal of Pharmaceutical Sciences, vol. 102, no. 3, pp. 1036-1053, 2013.
19. A. Xu, M. Yao, G. Xu et al., "A physical model for the size-dependent cellular uptake of nanoparticles modifed with cationic surfactants, " International Journal of Nanomedicine, vol. 7, pp. 3547-3554, 2012.
20. N. M. Khalil, T. C. F. do Nascimento, D. M. Casa et al., "Pharmacokinetics of curcumin-loaded PLGA and PLGA-PEG blend nanoparticles afer oral administration in rats, " Colloids and Surfaces B: Biointerfaces, vol. 101, pp. 353-360, 2013.
21. P. Aksungur, M. Demirbilek, E. B. Denkbąs, and N. Ü nlü, "Comparative evaluation of cyclosporine A/HP-CD-incorporated PLGA nanoparticles for development of effective ocular preparations, " Journal of Microencapsulation, vol. 29, no. 6, pp. 605-613, 2012.
22. Z. Li, K. Liu, P. Sun et al., "Poly(D, L-lactide-co-glycolide)/montmorillonite nanoparticles for improved oral delivery of exemestane, " Journal of Microencapsulation, vol. 30, no. 5, pp. 432-440, 2013.
23. A. Budhian, S. J. Siegel, and K. I. Winey, "Production of haloperidol-loaded PLGA nanoparticles for extended controlled drug release of haloperidol, " Journal of Microencapsula-tion, vol. 22, no. 7, pp. 773-785, 2005.
24. C. T. S. Turk, U. C. Oz, T. M. Serim, and C. Hascicek, "Formulation and optimization of nonionic surfactants emulsifed nimesulide-loaded PLGA-based nanoparticles by design of experiments, " AAPS PharmSciTech, vol. 15, no. 1, pp. 161-176, 2014.
25. V. Bhardwaj, D. D. Ankola, S. C. Gupta, M. Schneider, C.-M. Lehr, and M. N. V. R. Kumar, "PLGA nanoparticles stabilized with cationic surfactant: safety studies and application in oral delivery of paclitaxel to treat chemical-induced breast cancer in rat, " Pharmaceutical Research, vol. 26, no. 11, pp. 2495-2503, 2009.
26. C. Jin, L. Bai, H. Wu, W. Song, G. Guo, and K. Dou, "Cytotoxicity of paclitaxel incorporated in plga nanoparticles on hypoxic human tumor cells, " Pharmaceutical Research, vol. 26, no. 7, pp. 1776-1784, 2009.
27. S. K. Swaminathan, E. Roger, U. Toti, L. Niu, J. R. Ohlfest, and J. Panyam, "CD133-targeted paclitaxel delivery inhibits local tumor recurrence in amousemodel of breast cancer, " Journal of Controlled Release, vol. 171, no. 3, pp. 280-287, 2013.
28. S. Chowdhury, R. Guha, R. Trivedi, U. B. Kompella, A. Konar, and S. Hazra, "Pirfenidone nanoparticles improve corneal wound healing and prevent scarring following alkali burn, " PLoS ONE, vol. 8, no. 8, Article ID e70528, 2013.
29. R. M. Mainardes and R. C. Evangelista, "PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution, " International Journal of Pharmaceutics, vol. 290, no. 1-2, pp. 137-144, 2005.
30. P. Liu, Y. Sun, Q. Wang, Y. Sun, H. Li, and Y. Duan, "Intracellular trafcking and cellular uptake mechanism of mPEG-PLGA-PLL and mPEG-PLGA-PLL-Gal nanoparticles for targeted delivery to hepatomas, " Biomaterials, vol. 35, no. 2, pp. 760-770, 2014.
31. Y. C. Kuo and H. W. Yu, "Transport of saquinavir across human brain-microvascular endothelial cells by poly(lactide-co-glycolide) nanoparticles with surface poly-(glutamic acid), " International Journal of Pharmaceutics, vol. 416, no. 1, pp. 365-375, 2011.
32. T.-W. Chung, S.-S. Wang, and W.-J. Tsai, "Accelerating throm-bolysis with chitosan-coated plasminogen activators encapsulated in poly-(lactide-co-glycolide) (PLGA) nanoparticles, " Biomaterials, vol. 29, no. 2, pp. 228-237, 2008.
33. Y. Wang, P. Liu, Y. Duan et al., "Specifc cell targeting with APRPG conjugated PEG-PLGA nanoparticles for treating ovarian cancer, " Biomaterials, vol. 35, no. 3, pp. 983-992, 2014.
34. B. Sinha, B. Mukherjee, and G. Pattnaik, "Poly-lactide-co-glycolide nanoparticles containing voriconazole for pulmonary delivery: in vitro and in vivo study, " Nanomedicine, vol. 9, no. 1, pp. 94-104, 2013.
35. H. Mahdavi, H. Mirzadeh, H. Hamishehkar et al., "The effect of process parameters on the size and morphology of poly(D, L-lactide-co-glycolide) micro/nanoparticles prepared by an oil in oil emulsion/solvent evaporation technique, " Journal of Applied Polymer Science, vol. 116, no. 1, pp. 528-534, 2010.
36. T. S. J. Kashi, S. Eskandarion, M. Esfandyari-Manesh et al., "Improved drug loading and antibacterial activity of minocycline-loaded PLGA nanoparticles prepared by solid/oil/water ion pairing method, " International Journal of Nanomedicine, vol. 7, pp. 221-234, 2012.
37. P. M. Hughes, M. Boix, C. Sarrazin, and M. Do, "Oil-in-oil emulsifed polymeric implants containing a hypotensive lipid and prostamide, " United States patent US 8445027, May 2013.
38. E. Allémann, R. Gurny, and E. Doelker, "Preparation of aqueous polymeric nanodispersions by a reversible salting-out process: influence of process parameters on particle size, " International Journal of Pharmaceutics, vol. 87, no. 1-3, pp. 247-253, 1992.
39. E. Allemann, J.-C. Leroux, R. Gurny, and E. Doelker, "In vitro extended-release properties of drug-loaded poly(DL-lactic acid) nanoparticles produced by a salting-out procedure, " Pharmaceutical Research, vol. 10, no. 12, pp. 1732-1737, 1993.
40. H. Ibrahim, C. Bindschaedler, E. Doelker, P. Buri, and R. Gurny, "Aqueous nanodispersions prepared by a salting-out process, " International Journal of Pharmaceutics, vol. 87, no. 1-3, pp. 239-246, 1992.
41. S. Galindo-Rodriguez, E. Alĺemann, H. Fessi, and E. Doelker, "Physicochemical parameters associated with nanoparticle formation in the salting-out, emulsifcation-difusion, and nano-precipitation methods, " Pharmaceutical Research, vol. 21, no. 8, pp. 1428-1439, 2004.
42. B. Wang, M. Gou, X. Zheng et al., "Co-delivery honokiol and doxorubicin in MPEG-PLA nanoparticles, " Journal of Nanoscience and Nanotechnology, vol. 10, no. 7, pp. 4166-4172, 2010.
43. Y. N. Konan, R. Gurny, and E. Alĺemann, "Preparation and characterization of sterile and freeze-dried sub-200 nm nanoparti-cles, " International Journal of Pharmaceutics, vol. 233, no. 1-2, pp. 239-252, 2002.
44. M. Vettor, P. Perugini, S. Scalia et al., "Poly(D, L-lactide) nanoen-capsulation to reduce photoinactivation of a sunscreen agent, " International Journal of Cosmetic Science, vol. 30, no. 3, pp. 219-227, 2008.
45. M. Vettor, S. Bourgeois, H. Fessi et al., "Skin absorption studies of octyl-methoxycinnamate loaded poly(D, L-lactide) nanoparticles: estimation of the UV flter distribution and release behaviour in skin layers, " Journal of Microencapsulation, vol. 27, no. 3, pp. 253-262, 2010.
46. S. Gupta, A. Agarwal, N. K. Gupta, G. Saraogi, H. Agrawal, and G. P. Agrawal, "Galactose decorated PLGA nanoparticles for hepatic delivery of acyclovir, " Drug Development and Industrial Pharmacy, vol. 39, no. 12, pp. 1866-1873, 2013.
47. P. Liu, H. Yu, Y. Sun, M. Zhu, and Y. Duan, "A mPEG-PLGA-b-PLL copolymer carrier for adriamycin and siRNA delivery, " Biomaterials, vol. 33, no. 17, pp. 4403-4412, 2012.
48. R. Varshochian, M. Jeddi-Tehrani, A. R. Mahmoudi et al., "The protective effect of albumin on bevacizumab activity and stability in PLGA nanoparticles intended for retinal and choroidal neovascularization treatments, " European Journal of Pharmaceutical Sciences, vol. 50, no. 3-4, pp. 341-352, 2013.
49. N. Rescignano, L. Tarpani, R. Tiribuzi et al., "Protein encapsulation in biodegradable polymeric nanoparticles: morphology, fuorescence behaviour and stem cell uptake, " Macromolecular Bioscience, vol. 13, no. 9, pp. 1204-1212, 2013.
50. M. Alonso-Sande, A. des Rieux, V. Fievez et al., "Development of PLGA-mannosamine nanoparticles as oral protein carriers, " Biomacromolecules, vol. 14, no. 11, pp. 4046-4052, 2013.
51. S. H. Lee, Z. Zhang, and S.-S. Feng, "Nanoparticles of poly(lactide)-tocopheryl polyethylene glycol succinate (PLA-TPGS) copolymers for protein drug delivery, " Biomaterials, vol. 28, no. 11, pp. 2041-2050, 2007.
52. N. Samadi, A. Abbadessa, A. di Stefano et al., "The effect of lauryl capping group on protein release and degradation of poly(d, l-lactic-co-glycolic acid) particles, " Journal of Controlled Release, vol. 172, no. 2, pp. 436-443, 2013.
53. S. J. Fairley, S. R. Singh, A. N. Yilma et al., "Chlamydia trachoma-tis recombinant MOMP encapsulated in PLGA nanoparticles triggers primarily T helper 1 cellular and antibody immune responses in mice: a desirable candidate nanovaccine, " International Journal of Nanomedicine, vol. 8, pp. 2085-2099, 2013.
54. C. Colonna, R. Dorati, B. Conti, P. Caliceti, and I. Genta, "Sub-unit vaccine against S. aureus-mediated infections: setup of nano-sized polymeric adjuvant, " International Journal of Pharmaceutics, vol. 452, no. 1-2, pp. 390-401, 2013.
55. H. Cohen, R. J. Levy, J. Gao et al., "Sustained delivery and expression of DNA encapsulated in polymeric nanoparticles, " Gene Terapy, vol. 7, no. 22, pp. 1896-1905, 2000.
56. F. Li, J. Sun, H. Zhu, X. Wen, C. Lin, and D. Shi, "Preparation and characterization novel polymer-coated magnetic nanoparticles as carriers for doxorubicin, " Colloids and Surfaces B: Biointer-faces, vol. 88, no. 1, pp. 58-62, 2011.
57. M. Wang, Y. Zhang, J. Feng et al., "Preparation, characterization, and in vitro and in vivo investigation of chitosan-coated poly(d, l-lactide-co-glycolide) nanoparticles for intestinal delivery of exendin-4, " International Journal of Nanomedicine, vol. 8, pp. 1141-1154, 2013.
58. Y. Wang, P. Li, and L. Kong, "Chitosan-modifed PLGA nanoparticles with versatile surface for improved drug delivery, " AAPS PharmSciTech, vol. 14, no. 2, pp. 585-592, 2013.
59. S. M. Abdelghany, D. J. Quinn, R. J. Ingram et al., "Gentamicin-loaded nanoparticles show improved antimicrobial effects towards Pseudomonas aeruginosa infection, " International Journal of Nanomedicine, vol. 7, pp. 4053-4063, 2012.
60. C. Lecaroz, C. Gamazo, M. J. Renedo, and M. J. Blanco-Prieto, "Biodegradable micro-and nanoparticles as long-term delivery vehicles for gentamicin, " Journal of Microencapsulation, vol. 23, no. 7, pp. 782-792, 2006.
61. D. Cun, C. Foged, M. Yang, S. Frøkjær, and H. M. Nielsen, "Preparation and characterization of poly(dl-lactide-co-glycolide) nanoparticles for siRNA delivery, " International Journal of Pharmaceutics, vol. 390, no. 1, pp. 70-75, 2010.
62. Z. Zhang, S. Tongchusak, Y. Mizukami et al., "Induction of anti-tumor cytotoxic T cell responses through PLGA-nanoparticle mediated antigen delivery, " Biomaterials, vol. 32, no. 14, pp. 3666-3678, 2011.
63. M. Tafaghodi, A. Khamesipour, and M. R. Jaafari, "Immunization against leishmaniasis by PLGA nanospheres encapsulated with autoclaved Leishmania major (ALM) and CpG-ODN, " Parasitology Research, vol. 108, no. 5, pp. 1265-1273, 2011.
64. R. Coco, L. Plapied, V. Pourcelle et al., "Drug delivery to infamed colon by nanoparticles: comparison of diferent strategies, " International Journal of Pharmaceutics, vol. 440, no. 1, pp. 3-12, 2013.
65. M. Zaric, O. Lyubomska, O. Touzelet et al., "Skin dendritic cell targeting via microneedle arrays laden with antigen-encapsulated poly-d, l-lactide-co-glycolide nanoparticles induces efcient antitumor and antiviral immune responses, " ACS Nano, vol. 7, no. 3, pp. 2042-2055, 2013.
66. S. Sunoqrot, J. W. Bae, S. E. Jin, R. M. Pearson, Y. Liu, and S. Hong, "Kinetically controlled cellular interactions of polymer-polymer and polymer-liposome nanohybrid systems, " Bioconjugate Chemistry, vol. 22, no. 3, pp. 466-474, 2011.
67. S. Ribeiro, N. Hussain, and A. T. Florence, "Release of DNA from dendriplexes encapsulated in PLGA nanoparticles, " International Journal of Pharmaceutics, vol. 298, no. 2, pp. 354-360, 2005.
68. M. Chaturvedi, Y. Molino, B. Sreedhar, M. Khrestchatisky, and L. Kaczmarek, "Tissue inhibitor of matrix metalloproteinases-1 loaded poly(lactic-co-glycolic acid) nanoparticles for delivery across the blood-brain barrier, " International Journal of Nanomedicine, vol. 9, no. 1, pp. 575-588, 2014.
69. M. Afshari, K. Derakhshandeh, and L. Hosseinzadeh, "Characterisation, cytotoxicity and apoptosis studies of methotrexate-loaded PLGA and PLGA-PEG nanoparticles, " Journal of Microencapsulation, vol. 31, no. 3, pp. 239-245, 2014.
70. F. Ganachaud and J. L. Katz, "Nanoparticles and nanocap-sules created using the ouzo effect: spontaneous emulsifca-tion as an alternative to ultrasonic and high-shear devices, " ChemPhysChem, vol. 6, no. 2, pp. 209-216, 2005.
71. H. Fessi, F. Piusieux, J. P. Devissaguet, N. Ammoury, and S. Benita, "Nanocapsule formation by interfacial polymer deposition following solvent displacement, " International Journal of Pharmaceutics, vol. 55, no. 1, pp. R1-R4, 1989.
72. J. Huang, H. Zhang, Y. Yu et al., "Biodegradable self-assembled nanoparticles of poly(d, l-lactide-co-glycolide)/hyaluronic acid block copolymers for target delivery of docetaxel to breast cancer, " Biomaterials, vol. 35, no. 1, pp. 550-566, 2014.
73. R. Dinarvand, N. Sepehri, S. Manoochehri, and F. Atyabi, "Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents, " International Journal of Nanomedicine, vol. 6, pp. 877-895, 2011.
74. A. Kumar and K. K. Sawant, "Application of multiple regression analysis in optimization of anastrozole-loaded PLGA nanopar-ticles, " Journal of Microencapsulation, vol. 31, no. 2, pp. 105-114, 2014.
75. S. Şimsek, H. Eroglu, B. Kurum, and K. Ulubayram, "Brain targeting of Atorvastatin loaded amphiphilic PLGA-b-PEG nanoparticles, " Journal of Microencapsulation, vol. 30, no. 1, pp. 10-20, 2013.
76. C. P. Reis, N. Martinho, C. Rosado, A. S. Fernandes, and A. Roberto, "Design of polymeric nanoparticles and its applications as drug delivery systems for acne treatment, " Drug Development and Industrial Pharmacy, vol. 40, no. 3, pp. 409-417, 2014.
77. M. E. Ali and A. Lamprecht, "Polyethylene glycol as an alternative polymer solvent for nanoparticle preparation, " International Journal of Pharmaceutics, vol. 456, no. 1, pp. 135-142, 2013.
78. A. Paul, S. Das, J. Das, A. Samadder, and A. R. Khuda-Bukhsh, "Cytotoxicity and apoptotic signalling cascade induced by chelidonine-loaded PLGA nanoparticles in HepG2 cells in vitro and bioavailability of nano-chelidonine in mice in vivo, " Toxicology Letters, vol. 222, no. 1, pp. 10-22, 2013.
79. C. S. de Paula, A. C. Tedesco, F. L. Primo, J. M. C. Vilela, M. S. Andrade, and V. C. F. Mosqueira, "Chloroaluminium phthalocyanine polymeric nanoparticles as photosensitisers: photophysical and physicochemical characterisation, release and phototoxicity in vitro, " European Journal of Pharmaceutical Sciences, vol. 49, no. 3, pp. 371-381, 2013.
80. Z. H. Wang, Z. Y. Wang, C. S. Sun, C. Y. Wang, T. Y. Jiang, and S. L. Wang, "Trimethylated chitosan-conjugated PLGA nanopar-ticles for the delivery of drugs to the brain, " Biomaterials, vol. 31, no. 5, pp. 908-915, 2010.
81. H. Shen, X. Hu, M. Szymusiak, Z. J. Wang, and Y. Liu, "Orally administered nanocurcumin to attenuate morphine tolerance: comparison between negatively charged PLGA and partially and fully PEGylated nanoparticles, " Molecular Pharmaceutics, vol. 10, no. 12, pp. 4546-4551, 2013.
82. W. Tao, X. Zeng, T. Liu et al., "Docetaxel-loaded nanoparti-cles based on star-shaped mannitol-core PLGA-TPGS diblock copolymer for breast cancer therapy, " Acta Biomaterialia, vol. 9, no. 11, pp. 8910-8920, 2013.
83. T. Musumeci, C. A. Ventura, I. Giannone et al., "PLA/PLGA nanoparticles for sustained release of docetaxel, " International Journal of Pharmaceutics, vol. 325, no. 1-2, pp. 172-179, 2006.
84. C. W. Gan and S. S. Feng, "Transferrin-conjugated nanoparti-cles of Poly(lactide)-D-tocopheryl polyethylene glycol succi-nate diblock copolymer for targeted drug delivery across the blood-brain barrier, " Biomaterials, vol. 31, no. 30, pp. 7748-7757, 2010.
85. L. Martin-Banderas, J. Alvarez-Fuentes, M. Durán-Lobato et al., "Cannabinoid derivate-loaded PLGA nanocarriers for oral administration: formulation, characterization, and cytotoxicity studies, " International Journal of Nanomedicine, vol. 7, pp. 5793-5806, 2012.
86. H. Y. Kwon, J. Y. Lee, S. W. Choi, Y. Jang, and J. H. Kim, "Preparation of PLGA nanoparticles containing estrogen by emulsifcation-difusion method, " Colloids and Surfaces A: Physicochemical and Engineering Aspects, vol. 182, no. 1-3, pp. 123-130, 2001.
87. E. Vega, M. A. Egea, A. C. Calpena, M. Espina, and M. L. Garćia, "Role of hydroxypropyl-cyclodextrin on freeze-dried and gamma-irradiated PLGA and PLGA-PEG diblock copolymer nanospheres for ophthalmic furbiprofen delivery, " International Journal of Nanomedicine, vol. 7, pp. 1357-1371, 2012.
88. Y. C. Chen, W. Y. Hsieh, W. F. Lee, and D. T. Zeng, "Effects of surface modifcation of PLGA-PEG-PLGA nanoparticles on loperamide delivery efciency across the blood-brain barrier, " Journal of Biomaterials Applications, vol. 27, no. 7, pp. 909-922, 2013.
89. T. Musumeci, C. Bucolo, C. Carbone, R. Pignatello, F. Drago, and G. Puglisi, "Polymeric nanoparticles augment the ocular hypotensive effect of melatonin in rabbits, " International Journal of Pharmaceutics, vol. 440, no. 2, pp. 135-140, 2013.
90. S. S. Bhattacharyya, S. Paul, A. De et al., "Poly(lactide-co-glycolide) acid nanoencapsulation of a synthetic coumarin: cytotoxicity and bio-distribution in mice, in cancer cell line and interaction with calf thymus DNA as target, " Toxicology and Applied Pharmacology, vol. 253, no. 3, pp. 270-281, 2011.
91. H.-J. Jeon, Y.-I. Jeong, M.-K. Jang, Y.-H. Park, and J.-W. Nah, "Effect of solvent on the preparation of surfactant-free poly(DL-lactide-co-glycolide) nanoparticles and norfoxacin release characteristics, " International Journal of Pharmaceutics, vol. 207, no. 1-2, pp. 99-108, 2000.
92. W. P. Su, F. Y. Cheng, D. B. Shieh, C. S. Yeh, and W. C. Su, "PLGA nanoparticles codeliver paclitaxel and Stat3 siRNA to overcome cellular resistance in lung cancer cells, " International Journal of Nanomedicine, vol. 7, pp. 4269-4283, 2012.
93. H. Xie, Z.-G. She, S. Wang, G. Sharma, and J. W. Smith, "One-step fabrication of polymeric Janus nanoparticles for drug delivery, " Langmuir, vol. 28, no. 9, pp. 4459-4463, 2012.
94. V. Bojat, V. Balabanyan, and R. Alyautdin, "The entrapment of paclitaxel in PLGA nanoparticles increases its cytotoxicity against multiresistant cell line, " British Journal of Medicine and Medical Research, vol. 1, no. 4, pp. 306-319, 2011.
95. C. M. Moraes, A. P. de Matos, R. de Lima, A. H. Rosa, E. de Paula, and L. F. Fraceto, "Initial development and characterization of PLGA nanospheres containing ropivacaine, " Journal of Biological Physics, vol. 33, no. 5-6, pp. 455-461, 2007.
96. Y.-I. Jeong, Y.-H. Shim, C. Kim, G.-T. Lim, K.-C. Choi, and C. Yoon, "Effect of cryoprotectants on the reconstitution of surfactant-free nanoparticles of poly(DL-lactide-co-glycolide), " Journal of Microencapsulation, vol. 22, no. 6, pp. 593-601, 2005.
97. J. Ravindran, H. B. Nair, B. Sung, S. Prasad, R. R. Tek-mal, and B. B. Aggarwal, "Tymoquinone poly(lactide-co-glycolide) nanoparticles exhibit enhanced anti-proliferative, anti-infammatory, and chemosensitization potential, " Biochemical Pharmacology, vol. 79, no. 11, pp. 1640-1647, 2010.
98. J. Lalani, M. Rathi, M. Lalan, and A. Misra, "Protein func-tionalized tramadol-loaded PLGA nanoparticles: preparation, optimization, stability and pharmacodynamic studies, " Drug Development and Industrial Pharmacy, vol. 39, no. 6, pp. 854-864, 2013.
99. A. M. Paiva, R. A. Pinto, M. Teixeira et al., "Development of noncytotoxic PLGA nanoparticles to improve the effect of a new inhibitor of p53-MDM2 interaction, " International Journal of Pharmaceutics, vol. 454, no. 1, pp. 394-402, 2013.
100. S. A. Vitale and J. L. Katz, "Liquid droplet dispersions formed by homogeneous liquid-liquid nucleation: 'the ouzo effect', " Langmuir, vol. 19, no. 10, pp. 4105-4110, 2003.
101. T. Niwa, H. Takeuchi, T. Hino, N. Kunou, and Y. Kawashima, "Preparations of biodegradable nanospheres of water-soluble and insoluble drugs with D, L-lactide/glycolide copolymer by a novel spontaneous emulsifcation solvent difusion method, and the drug release behavior, " Journal of Controlled Release, vol. 25, no. 1-2, pp. 89-98, 1993.
102. M. H. El-Shabouri, "Positively charged nanoparticles for improving the oral bioavailability of cyclosporin-A, " International Journal of Pharmaceutics, vol. 249, no. 1-2, pp. 101-108, 2002.
103. H. Murakami, M. Kobayashi, H. Takeuchi, and Y. Kawashima, "Preparation of poly(DL-lactide-co-glycolide) nanoparticles by modifed spontaneous emulsifcation solvent difusion method, " International Journal of Pharmaceutics, vol. 187, no. 2, pp. 143-152, 1999.
104. T. Nakashima, M. Shimizu, and M. Kukizaki, "Membrane emul-sifcation by microporous glass, " Key Engineering Materials, vol. 61-62, pp. 513-516, 1992.
105. T. Nakashima, M. Shimizu, and M. Kukizaki, "Particle control of emulsion by membrane emulsifcation and its applications, " Advanced Drug Delivery Reviews, vol. 45, no. 1, pp. 47-56, 2000.
106. T. Hwang, T. J. Park, W. G. Koh, I. W. Cheong, S. W. Choi, and J. H. Kim, "Fabrication of nano-scale liposomes containing doxorubicin using Shirasu porous glass membrane, " Colloids and Surfaces A: Physicochemical and Engineering Aspects, vol. 392, no. 1, pp. 250-255, 2011.
107. G. H. Ma, M. Nagai, and S. Omi, "Preparation of uniform poly(lactide) microspheres by employing the Shirasu Porous Glass (SPG) emulsifcation technique, " Colloids and Surfaces A: Physicochemical and Engineering Aspects, vol. 153, no. 1-3, pp. 383-394, 1999.
108. H. Oha, P. Balakrishnana, Y. K. Oh, D. D. Kim, C. S. Yon, and H. G. Choi, "Effect of process parameters on nanoemulsion droplet size and distribution in SPG membrane emulsifcation, " International Journal of Pharmaceutics, vol. 404, pp. 191-197, 2011.
109. W. Liu, X.-L. Yang, and W. S. W. Ho, "Preparation of uniform-sized multiple emulsions and micro/nano particulates for drug delivery by membrane emulsifcation, " Journal of Pharmaceutical Sciences, vol. 100, no. 1, pp. 75-93, 2011.
110. C. Charcosset, I. Limayem, and H. Fessi, "The membrane emul-sifcation process-a review, " Journal of Chemical Technology and Biotechnology, vol. 79, no. 3, pp. 209-218, 2004.
111. Q. Wei, W. Wei, B. Lai et al., "Uniform-sized PLA nanoparticles: preparation by premix membrane emulsifcation, " International Journal of Pharmaceutics, vol. 359, no. 1-2, pp. 294-297, 2008.
112. Y. Yu, S. Tan, S. Zhao et al., "Antitumor activity of docetaxel-loaded polymeric nanoparticles fabricated by shirasu porous glass membrane-emulsifcation technique, " International Journal of Nanomedicine, vol. 8, pp. 2641-2652, 2013.
113. E. Imbuluzqueta, E. Elizondo, C. Gamazo et al., "Novel bioactive hydrophobic gentamicin carriers for the treatment of intracel-lular bacterial infections, " Acta Biomaterialia, vol. 7, no. 4, pp. 1599-1608, 2011.
114. E. Imbuluzqueta, C. Gamazo, H. Lana et al., "Hydrophobic gentamicin-loaded nanoparticles are effective against Bru-cella melitensis infection in mice, " Antimicrobial Agents and Chemotherapy, vol. 57, no. 7, pp. 3326-3333, 2013.
115. G. Dalwadi and B. Sunderland, "An ion pairing approach to increase the loading of hydrophilic and lipophilic drugs into PEGylated PLGA nanoparticles, " European Journal of Pharmaceutics and Biopharmaceutics, vol. 71, no. 2, pp. 231-242, 2009.
116. S. H. Choi and T. G. Park, "Hydrophobic ion pair formation between leuprolide and sodium oleate for sustained release from biodegradable polymeric microspheres, " International Journal of Pharmaceutics, vol. 203, no. 1-2, pp. 193-202, 2000.
117. L. Yang, F. Cui, K. Shi, D. Cun, and R. Wang, "Design of high payload PLGA nanoparticles containing melittinsodium dode-cyl sulfate complex by the hydrophobic ion-pairing technique, " Drug Development and Industrial Pharmacy, vol. 35, no. 8, pp. 959-968, 2009.
118. F. Cui, K. Shi, L. Zhang, A. Tao, and Y. Kawashima, "Biodegradable nanoparticles loaded with insulin-phospholipid complex for oral delivery: preparation, in vitro characterization and in vivo evaluation, " Journal of Controlled Release, vol. 114, no. 2, pp. 242-250, 2006.
119. H. Kim, B.-J. Lee, and H. Sah, "Reverse micelle-based microen-capsulation of oxytetracycline hydrochloride into poly-d, l-lactide-co-glycolide microspheres, " Drug Delivery, vol. 14, no. 2, pp. 95-99, 2007.
120. G. M. Whitesides, "The origins and the future of microfuidics, " Nature, vol. 442, no. 7101, pp. 368-373, 2006.
121. L. H. Hung and A. P. Lee, "Microfuidic devices for the synthesis of nanoparticles and biomaterials, " Journal of Medical and Biological Engineering, vol. 27, no. 1, pp. 1-6, 2007.
122. P. M. Valencia, O. C. Farokhzad, R. Karnik, and R. Langer, "Microfuidic technologies for accelerating the clinical translation of nanoparticles, " Nature Nanotechnology, vol. 7, no. 10, pp. 623-629, 2012.
123. A. Jahn, J. E. Reiner, W. N. Vreeland, D. L. DeVoe, L. E. Locascio, and M. Gaitan, "Preparation of nanoparticles by continuous-fow microfuidics, " Journal of Nanoparticle Research, vol. 10, no. 6, pp. 925-934, 2008.
124. S. Marre and K. F. Jensen, "Synthesis of micro and nanostruc-tures in microfuidic systems, " Chemical Society Reviews, vol. 39, no. 3, pp. 1183-1202, 2010.
125. L. Y. Yeo, H.-C. Chang, P. P. Y. Chan, and J. R. Friend, "Microfuidic devices for bioapplications, " Small, vol. 7, no. 1, pp. 12-48, 2011.
126. G. F. Christopher and S. L. Anna, "Microfuidic methods for generating continuous droplet streams, " Journal of Physics D: Applied Physics, vol. 40, no. 19, pp. R319-R336, 2007.
127. P. B. Umbanhowar, V. Prasad, and D. A. Weitz, "Monodisperse emulsion generation via drop break of in a colfowing stream, " Langmuir, vol. 16, no. 2, pp. 347-351, 2000.
128. H. Gu, M. H. G. Duits, and F. Mugele, "Droplets formation and merging in two-phase fow microfuidics, " International Journal of Molecular Sciences, vol. 12, no. 12, pp. 2572-2597, 2011.
129. T. Torsen, R. W. Roberts, F. H. Arnold, and S. R. Quake, "Dynamic pattern formation in a vesicle-generating microfu-idic device, " Physical Review Letters, vol. 86, no. 18, pp. 4163-4166, 2001.
130. H. Xie and J. W. Smith, "Fabrication of PLGA nanoparticles with a fuidic nanoprecipitation system, " Journal of Nanobiotechnol-ogy, vol. 8, article 18, 2010.
131. B. K. Johnson and R. K. Prud'homme, "Flash Nano p recipita-tion of organic actives and block copolymers using a confned impinging jets mixer, " Australian Journal of Chemistry, vol. 56, no. 10, pp. 1021-1024, 2003.
132. Z. N. Wei, W. Li, M. Seo, S. Xu, and E. Kumacheva, "Janus and ternary particles generated by microfuidic synthesis: design, synthesis, and self-assembly, " Journal of the American Chemical Society, vol. 128, no. 29, pp. 9408-9412, 2006.
133. S. L. Anna, N. Bontoux, and H. A. Stone, "Formation of dispersions using 'fow focusing' in microchannels, " Applied Physics Letters, vol. 82, no. 3, pp. 364-366, 2003.
134. R. Dreyfus, P. Tabeling, and H. Willaime, "Ordered and disordered patterns in two-phase fows in microchannels, " Physical Review Letters, vol. 90, no. 14, Article ID 144505, 2003.
135. M. J. Cózar-Bernal, M. A. Holgado, J. L. Arias et al., "Insulin-loaded PLGA microparticles: fow focusing versus double emulsion/solvent evaporation, " Journal of Microencapsulation, vol. 28, no. 5, pp. 430-441, 2011.
136. M. A. Holgado, M. J. Cózar-Bernal, S. Salas, J. L. Arias, J. Álvarez-Fuentes, and M. Ferńandez-Aŕevalo, "Protein-loaded PLGA microparticles engineered by fow focusing: physico-chemical characterization and protein detection by reversed-phase HPLC, " International Journal of Pharmaceutics, vol. 380, no. 1-2, pp. 147-154, 2009.
137. L. Martin-Banderas, M. Flores-Masquera, P. Riesco-Chueca et al., "Flow focusing: a versatile technology to produce size-controlled and specifc-morphology microparticles, " Small, vol. 1, no. 7, pp. 688-692, 2005.
138. L. Martin-Banderas, E. Sáez-Fernández, M. Á. Holgado et al., "Biocompatible gemcitabine-based nanomedicine engineered by fow focusing for efcient antitumor activity, " International Journal of Pharmaceutics, vol. 443, no. 1-2, pp. 103-109, 2013.
139. R. Karnik, F. Gu, P. Basto et al., "Microfuidic platform for controlled synthesis of polymeric nanoparticles, " Nano Letters, vol. 8, no. 9, pp. 2906-2912, 2008.
140. J. M. Lim, N. Bertrand, P. M. Valencia et al., "Parallel microfu-idic synthesis of size-tunable polymeric nanoparticles using 3D fow focusing towards in vivo study, " Nanomedicine: Nanotech-nology, Biology, and Medicine, vol. 10, no. 2, pp. 401-409, 2014.
141. R. Krishnamurthy, J. A. Lumpkin, and R. Sridhar, "Inactiva-tion of lysozyme by sonication under conditions relevant to microencapsulation, " International Journal of Pharmaceutics, vol. 205, no. 1-2, pp. 23-34, 2000.
142. C. Perez, A. Sanchez, D. Putnam, D. Ting, R. Langer, and M. J. Alonso, "Poly(lactic acid)-poly(ethylene glycol) nanoparticles as new carriers for the delivery of plasmid DNA, " Journal of Controlled Release, vol. 75, no. 1-2, pp. 211-224, 2001.
143. P. G. Shao and L. C. Bailey, "Porcine insulin biodegradable polyester microspheres: stability and in vitro release characteristics, " Pharmaceutical Development and Technology, vol. 5, no. 1, pp. 1-9, 2000.
144. M. A. Ibrahim, A. Ismail, M. I. Fetouh, and A. Göpferich, "Stability of insulin during the erosion of poly(lactic acid) and poly(lactic-co-glycolic acid) microspheres, " Journal of Controlled Release, vol. 106, no. 3, pp. 241-252, 2005.
145. G. Zhu, S. R. Mallery, and S. P. Schwendeman, "Stabilization of proteins encapsulated in injectable poly(lactide-co-glycolide), " Nature Biotechnology, vol. 18, no. 1, pp. 52-57, 2000.
146. Y.-P. Li, Y.-Y. Pei, X.-Y. Zhang et al., "PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats, " Journal of Controlled Release, vol. 71, no. 2, pp. 203-211, 2001.
147. D. T. Martin, C. J. Hoimes, H. Z. Kaimakliotis et al., "Nanopar-ticles for urothelium penetration and delivery of the histone deacetylase inhibitor belinostat for treatment of bladder cancer, " Nanomedicine: Nanotechnology, Biology, and Medicine, vol. 9, no. 8, pp. 1124-1134, 2013.
148. S. S. Vasudev, S. Ahmad, R. Parveen et al., "Formulation of PEG-ylated L-asparaginase loaded poly(lactide-co-glycolide) nanoparticles: Influence of PEGylation on enzyme loading, activity and in vitro release, " Pharmazie, vol. 66, no. 12, pp. 956-960, 2011.
149. J. X. Zhang and K. J. Zhu, "An improvement of double emulsion technique for preparing bovine serum albumin-loaded PLGA microspheres, " Journal of Microencapsulation, vol. 21, no. 7, pp. 775-785, 2004.
150. B. Kirthivasan, D. Singh, M. M. Bommana, S. L. Raut, E. Squil-lante, and M. Sadoqi, "Active brain targeting of a fuorescent P-gp substrate using polymeric magnetic nanocarrier system, " Nanotechnology, vol. 23, no. 25, Article ID 255102, 2012.
151. F. Ito, H. Fujimori, and K. Makino, "Factors afecting the loading efciency of water-soluble drugs in PLGA microspheres, " Colloids and Surfaces B: Biointerfaces, vol. 61, no. 1, pp. 25-29, 2008.
152. L. Cheng, C. Jin, W. Lv, Q. Ding, and X. Han, "Developing a highly stable PLGA-mPEG nanoparticle loaded with cisplatin for chemotherapy of ovarian cancer, " PLoS ONE, vol. 6, no. 9, Article ID e25433, 2011.
153. P. D. Berkman and R. V. Calabrese, "dispersion of viscous liquids by turbulent fow in a static mixer, " AIChE Journal, vol. 34, no. 4, pp. 602-609, 1988.
154. R. K. Takur, Ch. Vial, K. D. P. Nigam, E. B. Nauman, and G. Djelveh, "Static mixers in the process industries-a review, " Chemical Engineering Research and Design, vol. 81, no. 7, pp. 787-826, 2003.
155. T. Lemenand, D. D. Valle, Y. Zellouf, and H. Peerhossaini, "Droplets formation in turbulent mixing of two immiscible fuids in a new type of static mixer, " International Journal of Multiphase Flow, vol. 29, no. 5, pp. 813-840, 2003.
156. Y. F. Maa and C. Hsu, "Liquid-liquid emulsifcation by static mixers for use in microencapsulation, " Journal of Microencap-sulation, vol. 13, no. 4, pp. 419-433, 1996.
157. S. I. Lyons and S. G. Wright, "Method and apparatus for preparing microparticles using in-line extraction, " United States Patent US 6705757, Alkermes Controlled Terapeutic II, 2004.
158. M. E. Rickey, M. Ramstack, and D. H. Lewis, "Preparation of biodegradable biocompatible microparticles containing a bioactive agent, " United States Patent US 6403114, Alkermes Controlled Terapeutic II, 2002.
159. S. Freitas, B. Rudolf, H. P. Merkle, and B. Gander, "Flow-through ultrasonic emulsifcation combined with static micromixing for aseptic production of microspheres by solvent extraction, " European Journal of Pharmaceutics and Biopharmaceutics, vol. 61, no. 3, pp. 181-187, 2005.
160. C. Wischke and H.-H. Borchert, "Influence of the primary emulsifcation procedure on the characteristics of small protein-loaded PLGA microparticles for antigen delivery, " Journal of Microencapsulation, vol. 23, no. 4, pp. 435-448, 2006.
161. Y. Dong, W. K. Ng, S. Shen, S. Kim, and R. B. H. Tan, "Solid lipid nanoparticles: continuous and potential large-scale nanoprecipitation production in static mixers, " Colloids and Surfaces B: Biointerfaces, vol. 94, pp. 68-72, 2012.
162. Y. Dong, W. K. Ng, S. Shen, S. Kim, and R. B. H. Tan, "Scalable ionic gelation synthesis of chitosan nanoparticles for drug delivery in static mixers, " Carbohydrate Polymers, vol. 94, no. 2, pp. 940-945, 2013.
163. J. Podobinski, M. Ramstack, and D. S. Dickey, "Methods and systems for generating nanoparticles, " Inventors: Cerulean Pharma Inc. Assignee, US Patent no. 8618240, 2013.
164. K. Ouzineb, C. Lord, N. Lesauze, C. Graillat, P. A. Tanguy, and T. McKenna, "Homogenisation devices for the production of miniemulsions, " Chemical Engineering Science, vol. 61, no. 9, pp. 2994-3000, 2006.
165. G. Garćia del Barrio, J. Hendry, M. J. Renedo, J. M. Irache, and F. J. Novo, "In vivo sustained release of adenoviral vectors from poly(D, L-lactic-co-glycolic) acid microparticles prepared by TROMS, " Journal of Controlled Release, vol. 94, no. 1, pp. 229-235, 2004.
166. D. M. Santos, M. W. Carneiro, T. R. de Moura et al., "PLGA nanoparticles loaded with KMP-11 stimulate innate immunity and induce the killing of Leishmania, " Nanomedicine, vol. 9, no. 7, pp. 985-995, 2013.
167. Y. Liu, C. Cheng, R. K. Prud'homme, and R. O. Fox, "Mixing in a multi-inlet vortex mixer (MIVM) for fash nano-precipitation, " Chemical Engineering Science, vol. 63, no. 11, pp. 2829-2842, 2008.
168. Y. Liu, Z. Tong, and R. K. P. Homme, "Stabilized polymeric nanoparticles for controlled and efcient release of bifenthrin, " Pest Management Science, vol. 64, no. 8, pp. 808-812, 2008.
169. Y. Shi, J. C. Cheng, R. O. Fox, and M. G. Olsen, "Measurements of turbulence in a microscale multi-inlet vortex nanoprecipita-tion reactor, " Journal of Micromechanics and Microengineering, vol. 23, no. 7, Article ID 075005, 2013.
170. K. K. Cheng, C. F. Yeung, S. W. Ho, S. F. Chow, A. H. L. Chow, and L. Baum, "Highly stabilized curcumin nanoparticles tested in an in vitro blood-brain barrier model and in Alzheimer's disease Tg2576 Mice, " The AAPS Journal, vol. 15, no. 2, pp. 324-336, 2012.
171. A. Aravind, S. H. Varghese, S. Veeranarayanan et al., "Aptamer-labeled PLGA nanoparticles for targeting cancer cells, " Cancer Nanotechnology, vol. 3, no. 1-6, pp. 1-12, 2012.
172. N. Schleich, P. Sibret, P. Danhier et al., "Dual anticancer drug/superparamagnetic iron oxide-loaded PLGA-based nanoparticles for cancer therapy and magnetic resonance imaging, " International Journal of Pharmaceutics, vol. 447, no. 1-2, pp. 94-101, 2013.
173. M. B. Heo and Y. T. Lim, "Programmed nanoparticles for combined immunomodulation, antigen presentation and tracking of immunotherapeutic cells, " Biomaterials, vol. 35, no. 1, pp. 590-600, 2014.
174. H. Wang, Y. Zhao, Y. Wu et al., "Enhanced anti-tumor efcacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles, " Biomaterials, vol. 32, no. 32, pp. 8281-8290, 2011.
175. X. Zhang, G. Chen, L. Wen et al., "Novel multiple agents loaded PLGA nanoparticles for brain delivery via inner ear administration: in vitro and in vivo evaluation, " European Journal of Pharmaceutical Sciences, vol. 48, no. 4-5, pp. 595-603, 2013.
176. Y. B. Patil, S. K. Swaminathan, T. Sadhukha, L. Ma, and J. Panyam, "The use of nanoparticle-mediated targeted gene silencing and drug delivery to overcome tumor drug resistance, " Biomaterials, vol. 31, no. 2, pp. 358-365, 2010.
177. Y. Cui, Q. Xu, P. K. H. Chow, D. Wang, and C. H. Wang, "Transferrin-conjugated magnetic silica PLGA nanoparticles loaded with doxorubicin and paclitaxel for brain glioma treatment, " Biomaterials, vol. 34, no. 33, pp. 8511-8520, 2013.
178. X. Yuan, S. Naguib, and Z. Wu, "Recent advances of siRNA delivery by nanoparticles, " Expert Opinion on Drug Delivery, vol. 8, no. 4, pp. 521-536, 2011.
179. M. V. Yezhelyev, L. Qi, R. M. O'Regan, S. Nie, and X. Gao, "Proton-sponge coated quantum dots for siRNA delivery and intracellular imaging, " Journal of the American Chemical Society, vol. 130, no. 28, pp. 9006-9012, 2008.
180. Y. Zhou, L. Zhang, W. Zhao, Y. Wu, C. Zhu, and Y. Yang, "Nanoparticle-mediated delivery of TGF-1 miRNA plasmid for preventing fexor tendon adhesion formation, " Biomaterials, vol. 34, no. 33, pp. 8269-8278, 2013.
181. Y. Wang, S. Gao, W.-H. Ye, H. S. Yoon, and Y.-Y. Yang, "Co-delivery of drugs and DNA from cationic core-shell nanopar-ticles self-assembled from a biodegradable copolymer, " Nature Materials, vol. 5, no. 10, pp. 791-796, 2006.
182. X. Yuan, B. A. Shah, N. K. Kotadia, J. Li, H. Gu, and Z. Wu, "The development and mechanism studies of cationic chitosan-modifed biodegradable PLGA nanoparticles for ef-cient siRNA drug delivery, " Pharmaceutical Research, vol. 27, no. 7, pp. 1285-1295, 2010.
183. D. N. Nguyen, J. J. Green, J. M. Chan, R. Langer, and D. G. Anderson, "Polymeric materials for gene delivery and DNA vaccination, " Advanced Materials, vol. 21, no. 8, pp. 847-867, 2009.
184. F. Ito, Y. Uchida, and Y. Murakami, "Facile technique for preparing organic-inorganic composite particles: monodis-perse poly(lactide-co-glycolide) (PLGA) particles having silica nanoparticles on the surface, " Colloids and Surfaces A: Physico-chemical and Engineering Aspects, vol. 361, no. 1-3, pp. 109-117, 2010.
185. J. M. Chan, L. Zhang, K. P. Yuet et al., "PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery, " Biomaterials, vol. 30, no. 8, pp. 1627-1634, 2009.
186. G. Ling, P. Zhang, W. Zhang et al., "Development of novel self-assembled DS-PLGA hybrid nanoparticles for improving oral bioavailability of vincristine sulfate by P-gp inhibition, " Journal of Controlled Release, vol. 148, no. 2, pp. 241-248, 2010.
187. B. Mandal, H. Bhattacharjee, N. Mittal et al., "Core-shell-type lipid-polymer hybrid nanoparticles as a drug delivery platform, " Nanomedicine: Nanotechnology, Biology, and Medicine, vol. 9, no. 4, pp. 474-491, 2013.
188. M. Zheng, C. Yue, Y. Ma et al., "Single-step assembly of DOX/ICG loaded lipid-polymer nanoparticles for highly effective chemo-photothermal combination therapy, " ACS Nano, vol. 7, no. 3, pp. 2056-2067, 2013.
189. S. Sengupta, D. Eavarone, I. Capila et al., "Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system, " Nature, vol. 436, no. 7050, pp. 568-572, 2005.
190. F. Huang, M. You, T. Chen, G. Zhu, H. Liang, and W. Tan, "Self-assembled hybrid nanoparticles for targeted co-delivery of two drugs into cancer cells, " Chemical Communications, vol. 50, no. 23, pp. 3103-3105, 2014.
191. Y. Wu and R. L. Clark, "Electrohydrodynamic atomization: a versatile process for preparing materials for biomedical applications, " Journal of Biomaterials Science, Polymer Edition, vol. 19, no. 5, pp. 573-601, 2008.
192. S. Labbaf, S. Deb, G. Cama, E. Stride, and M. Edirisinghe, "Preparation of multicompartment sub-micron particles using a triple-needle electrohydrodynamic device, " Journal of Colloid and Interface Science, vol. 409, pp. 245-254, 2013.
193. M. C. Branco and J. P. Schneider, "Self-assembling materials for therapeutic delivery, " Acta Biomaterialia, vol. 5, no. 3, pp. 817-831, 2009.
194. F. Ahmed, R. I. Pakunlu, A. Brannan, F. Bates, T. Minko, and D. E. Discher, "Biodegradable polymersomes loaded with both paclitaxel and doxorubicin permeate and shrink tumors, inducing apoptosis in proportion to accumulated drug, " Journal of Controlled Release, vol. 116, no. 2, pp. 150-158, 2006.
195. Y. Zhang, H.F. Chan, and K.W. Leong, "Advanced materials and processing for drug delivery: the past and the future, " Advanced Drug Delivery Reviews, vol. 65, no. 1, pp. 104-120, 2013.
196. "ICH Harmonized Tripartite Guideline-Impurities: Guideline for residual solvents Q3C(R5), " March 2010.
197. J. Herrmann and R. Bodmeier, "Biodegradable, somatostatin acetate containing microspheres prepared by various aqueous and non-aqueous solvent evaporation methods, " European Journal of Pharmaceutics and Biopharmaceutics, vol. 45, no. 1, pp. 75-82, 1998.
198. F. J. Wang and C. H. Wang, "Sustained release of etanidazole from spray dried microspheres prepared by non-halogenated solvents, " Journal of Controlled Release, vol. 81, no. 3, pp. 263-280, 2002.
199. I. J. Castellanos and K. Griebenow, "Improved chymotrypsin stability upon encapsulation in PLGA microspheres by solvent replacement, " Pharmaceutical Research, vol. 20, no. 11, pp. 1873-1880, 2003.
200. F. T. Meng, G. H. Ma, W. Qiu, and Z. G. Su, "W/O/W double emulsion technique using ethyl acetate as organic solvent: effects of its difusion rate on the characteristics of micropar-ticles, " Journal of Controlled Release, vol. 91, no. 3, pp. 407-416, 2003.
201. Y. Yeo, A. U. T. Chen, O. A. Basaran, and K. Park, "Microencap-sulation of drug by solvent exchange, " United States patent US 6599627, Purdue Research Fouondation, West Lafayette, Ind, USA, 2003.
202. A. Matsumoto, T. Kitazawa, J. Murata, Y. Horikiri, and H. Yama-hara, "A novel preparation method for PLGA microspheres using non-halogenated solvents, " Journal of Controlled Release, vol. 129, no. 3, pp. 223-227, 2008.
203. H. Hamishehkar, J. Emami, A. R. Najafabadi et al., "The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method, " Colloids and Surfaces B: Biointerfaces, vol. 74, no. 1, pp. 340-349, 2009.
204. H.-Y. Im and H. Sah, "Ammonolysis-based microencapsulation technique using isopropyl formate as dispersed solvent, " International Journal of Pharmaceutics, vol. 382, no. 1-2, pp. 130-138, 2009.
205. W. M. Obeidat, "Recent patents review in microencapsulation of pharmaceuticals using the emulsion solvent removal methods, " Recent Patents on Drug Delivery and Formulation, vol. 3, no. 3, pp. 178-192, 2009.
206. D. Allhenn and A. Lamprecht, "Microsphere preparation using the untoxic solvent glycofurol, " Pharmaceutical Research, vol. 28, no. 3, pp. 563-571, 2011.
207. D. T. Birnbaum, J. D. Kosmala, D. B. Henthorn, and L. Brannon-Peppas, "Controlled release of estradiol from PLAGA microparticles: the effect of organic phase solvent on encapsulation and release, " Journal of Controlled Release, vol. 65, no. 3, pp. 375-387, 2000.
208. M. Li, O. Rouaud, and D. Poncelet, "Microencapsulation by solvent evaporation: state of the art for process engineering approaches, " International Journal of Pharmaceutics, vol. 363, no. 1-2, pp. 26-39, 2008.
209. C. B'Hymer, "Residual solvent testing: a review of gas-chromatographic and alternative techniques, " Pharmaceutical Research, vol. 20, no. 3, pp. 337-344, 2003.
210. N. Desai, "Challenges in development of nanoparticle-based therapeutics, " AAPS Journal, vol. 14, no. 2, pp. 282-295, 2012.
211. I. P. Kaur, V. Kakkar, P. K. Deol, M. Yadav, M. Singh, and I. Sharma, "Issues and concerns in nanotech product development and its commercialization, " Journal of Controlled Release, vol. 193, pp. 51-62, 2014.